Is NCT02889367 results overdue?

Yes — results are overdue. Primary completion was 2017-03-04; the FDAAA-801 reporting deadline (2018-03-04) passed 3031 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants

NCT ID	NCT02889367 ↗
Sponsor	Janssen Research & Development, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2017-03-04 (ACTUAL)
Reporting deadline	2018-03-04 (completion + 365d)
Days overdue	3031
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `b7e09442d7f4f8c6…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02889367. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.